Monte Rosa Therapeutics (GLUE) announced the appointment of Eric Hughes, M.D, Ph.D., to its Board of Directors. Dr. Hughes is currently Executive Vice President, Global R&D and Chief Medical Officer of Teva Pharmaceutical (TEVA)
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLUE:
- Monte Rosa announces closing of global license agreement with Novartis
- Monte Rosa Therapeutics presents preclinical data on CDK2 degrader
- Monte Rosa Highlights Promising Results in Cancer Study
- Monte Rosa Therapeutics provides development progress on ongoing MRT-2359 study
- Monte Rosa Therapeutics Expands Pipeline with Novartis Deal